Cardinal Health, Inc. (CAH) Stock Price: $223.85+2.69 (+1.22%)
At close: Jun 12, 2026, 4:00 PM ET
The closing share price for Cardinal Health, Inc. (CAH) stock was $223.85 for Friday, June 12, 2026, up 1.22% on the day.
Longer view (total return, dividends reinvested): past 12 months +41.1% · 3-year avg +39.2%/yr · 5-year avg +33.5%/yr
CAH Price Chart
CAH Key Metrics
See All MetricsLAST CLOSE PRICE
$223.85
52-WEEK RANGE
$137.75 - $233.60
BETA
0.53
% FROM 52W HIGH
-4.17%
MARKET CAP
$52.43B
DIVIDEND YIELD
0.91%
PE RATIO
trailing TTM
34.23
PE RATIO (FWD)
next-FY estimate
18.64
P/B RATIO
N/A
DEBT / EQUITY
-3.36
REVENUE TTM
$250.55B
NET INCOME TTM
$1.56B
NET PROFIT MARGIN TTM
0.62%
TTM TOTAL RETURN
+41.06%
3Y TOTAL RETURN
+39.20%
5Y TOTAL RETURN
+33.46%
CAH Earnings Preview
Next Earnings Date
Aug 11, 2026
57 days away
EPS Estimate
2.41
Revenue Est.
$65.22B
Last Quarter Results
EPS
$3.17
vs Estimate
$2.79
Revenue
$60.94B
vs Estimate
$62.10B
CAH Analyst Ratings
Consensus Rating
Based on 15 analysts
Average Price Target
$245.27
+9.6% upside
Low
$215.00
Current
$223.85
High
$275.00
CAH Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q3 2028 | $3.68 | $3.77 | $3.85 | 3 |
| Q4 2028 | $3.78 | $3.88 | $3.96 | 3 |
| Q1 2029 | $4.24 | $4.35 | $4.44 | 4 |
| Q2 2029 | $3.66 | $3.75 | $3.83 | 3 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $11.70 | $12.01 | $12.19 | 10 |
| FY 2028 | $10.19 | $13.52 | $15.79 | 5 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q3 2028 | $77.93B | $79.46B | $80.77B | 1 |
| Q4 2028 | $78.79B | $80.33B | $81.65B | 2 |
| Q1 2029 | $75.31B | $76.78B | $78.05B | 3 |
| Q2 2029 | $77.16B | $78.66B | $79.96B | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $272.13B | $277.11B | $282.69B | 12 |
| FY 2028 | $298.77B | $299.22B | $299.67B | 12 |
Source: FMP Analyst Consensus Estimates. Forward P/E uses the next-fiscal-year consensus EPS estimate (the same value shown in the Key Metrics strip).
Related Stocks
HealthcareCAH Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1CAH | $52.43B | $223.85 | +1.22% | +41.06% | +33.46% | +14.21% | — |
| 2BDX | $52.98B | $146.24 | -0.75% | +9.25% | -2.99% | +2.80% | vs CAH |
| 3COR | $54.80B | $281.67 | +0.07% | -3.81% | +19.86% | +17.22% | vs CAH |
| 4HUM | $45.53B | $379.22 | +2.86% | +64.02% | -1.01% | +8.24% | vs CAH |
| 5IDXX | $44.24B | $560.88 | +0.53% | +6.45% | -0.82% | +20.22% | vs CAH |
| 6REGN | $63.06B | $612.14 | +0.11% | +17.95% | +3.26% | +5.19% | vs CAH |
CAH Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Jason Hollar